Ventana Medical Systems, Inc.: FDA filings under this applicant name
FDA lists 46 510(k) clearances under 2 spellings of the applicant name “Ventana Medical Systems, Inc.” (first 1992, latest 2024), plus 13 PMA and 3 De Novo decisions, across 25 product codes in 4 review panels. Median 510(k) review time under this name: 272 days. Since 2017 the median was 208 days, against 158 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Roche Diagnostics, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 5 | 248 |
| 2013 | 4 | 460 |
| 2014 | 1 | 24 |
| 2015 | 1 | 275 |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 1 | 266 |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 1 | 151 |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 2 | 181 |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Ventana Medical Systems, Inc. took a median 208 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 158 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DEH | Lambda, Antigen, Antiserum, Control | 17 | 17 |
| NQN | Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity | 6 | 6 |
| DEM | Alpha-1-Antitrypsin, Antigen, Antiserum, Control | 5 | 5 |
| NOT | Microscope, Automated, Image Analysis, Operator Intervention | 4 | 4 |
| DEY | Igm, Peroxidase, Antigen, Antiserum, Control | 3 | 3 |
| DFD | Kappa, Peroxidase, Antigen, Antiserum, Control | 3 | 3 |
| PLS | Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1 | 3 | 0 |
| NYQ | Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer | 2 | 0 |
| PRB | Cervical Intraepithelial Neoplasia (Cin) Test System | 2 | 1 |
| PSY | Whole Slide Imaging System | 2 | 2 |
Plus 15 more product codes.
Review panels
- Pathology (38)
- Immunology (22)
- Medical Genetics (1)
- Microbiology (1)
Most recent Ventana Medical Systems, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K242783 | Roche Digital Pathology Dx | PSY | 2024-12-17 | 92 |
| K232879 | Roche Digital Pathology Dx (VENTANA DP 200) | PSY | 2024-06-14 | 270 |
| K212176 | CINtec Histology | PRB | 2021-12-10 | 151 |
| K172471 | VENTANA CD30 (Ber-H2) RxDx Assay | DEH | 2018-05-08 | 266 |
| K142965 | Virtuoso System for IHC PR (1E2) using iScan HT | OEO | 2015-07-16 | 275 |
| K140465 | VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER | NQN | 2014-03-20 | 24 |
| K130515 | VIRTUOSO SYSTEM FOR IHC ER (SPI) | NQN | 2013-11-22 | 268 |
| K121516 | VIRTUOSO SYSTEM FOR IHC HER2 (4B5) | NQN | 2013-09-26 | 492 |
| K122143 | VIRTUOSO SYSTEM FOR IHC PR (1E2) BENCHMARK ULTRA STAINER | NQN | 2013-09-19 | 427 |
| K121033 | VIRTUOSO SYSTEM FOR IHC KI-67 (30-9) | NOT | 2013-09-06 | 519 |
36 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN240025 | De Novo | Kappa And Lambda Immunoglobulin Light Chain In Situ Hybridization Mrna Probe Detection Kit | 2024-12-05 |
| P230018 | PMA | VENTANA CLDN18 (43-14A) RxDx Assay | 2024-10-18 |
| P220006 | PMA | VENTANA FOLR1 (FOLR-2.1) RxDx Assay | 2022-11-14 |
| P200019 | PMA | VENTANA MMR RxDx Panel | 2021-04-22 |
| P190031 | PMA | HER2 Dual ISH DNA Probe Cocktail | 2020-07-28 |
Recalls
56 product recalls in 19 recall events; 5 initiated in the last five years. Most recent: 2026-04-20.
1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Roche Molecular Systems, Inc. (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Ventana Medical Systems, Inc. (60)
- Ventana Medical Systems (2)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Ventana, Inc. (1 510(k)s)
- Ventana Medical Sytems, Inc. (1 510(k)s)
- Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) (0 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Ventana Medical Systems, Inc.?
FDA lists 46 510(k) clearances under 2 spellings of the applicant name “Ventana Medical Systems, Inc.” (first 1992, latest 2024), plus 13 PMA and 3 De Novo decisions, across 25 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Ventana Medical Systems, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Ventana Medical Systems, Inc. is 272 days. Since 2017: 208 days, versus 158 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Ventana Medical Systems, Inc.?
The most frequent FDA product codes under this applicant name are DEH (Lambda, Antigen, Antiserum, Control, 17); NQN (Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity, 6); DEM (Alpha-1-Antitrypsin, Antigen, Antiserum, Control, 5).
Next steps
- See all 46 Ventana Medical Systems, Inc. clearances with predicates and recalls
- Run predicate analysis for product code DEH, Ventana Medical Systems, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.